Apellis Pharmaceuticals Inc. (APLS)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Deerfield ManagementBOND

James E. Flynn

64,825,000 $69,727 1.69%
2.
Farallon Capital

Thomas Steyer

2,275,000 $68,637 +2% 0.48%
3. 2,202,258 $66,442 +61% 0.01%
4. 1,866,108 $56,300 -10% 2.16%
5.
Millennium Management

Israel Englander

916,703 $27,657 -15% 0.03%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$31.81 5,000 Director 5,000 2020-05-08 Filing
$37.00 540,540 Large Shareholder 12,556,342 2020-01-13 Filing
$29.71 11,699 Officer 11,699 2019-08-29 Filing
$17.00 441,176 Large Shareholder 12,015,802 2019-03-11 Filing
$19.84 40,000 Large Shareholder 11,574,626 2018-09-21 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$48.25 600 Officer 33,177 2020-12-01 Filing
$39.38 5,000 Officer, Director 1,078,079 2020-11-16 Filing
$39.38 2,500 Director 669,544 2020-11-16 Filing
$31.09 600 Officer 27,725 2020-11-02 Filing
$35.00 2,500 Director 669,544 2020-10-15 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 66,855 $2,017,014 0%
2. 14,153 $426,996 0%
3. 10,452,808 $315,361 0.06%
4. 5,980,261 $180,424 0%
5. 5,028,289 $151,703 1.14%
News See All